About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Organ, tissue and cell donation is one of the greatest acts of generosity and solidarity that an individual can do, and we strive to ensure that the maximum number of people benefit from it.
We are a multidisciplinary group of professionals who investigate the search for innovative strategies to optimize the process of donation, preservation, processing, and transplantation of organs, tissues and cells in order to increase their availability, expand their functionality, and improve their quality and safety, so they contribute to better health outcomes.
We deepen into the characterization of the damaging mechanisms that operate in the ischemia-reperfusion process during donation and transplantation in order to develop practices that allow us to prevent, minimize or treat them.
PMID: 33388189 Journal: JOURNAL FRANCAIS D OPHTALMOLOGIE Year: 2021 Reference: J Fr Ophtalmol. 2021 Apr;44(4):618-619. doi: 10.1016/j.jfo.2020.07.006. Epub 2020 Dec 30. Impact factor: Publication type: Letter or abstract Authors: Azarfane, B; Berges, M; Jurado, E; Kirkegaard, E; Puig, J et al. DOI: 10.1016/j.jfo.2020.07.006
PMID: 33722884 Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Year: 2021 Reference: Antimicrob Agents Chemother. 2021 May 18;65(6). pii: AAC.02174-20. doi: 10.1128/AAC.02174-20. Print 2021 May 18. Impact factor: Publication type: Paper in international publication Authors: Berastegui, Cristina; Bravo, Carles; Campany-Herrero, David; Campillo, Nuria; Deu, Maria; Grau, Santiago; Len, Oscar; Los-Arcos, Ibai; Martin-Gomez, Maria Teresa; Sacanell, Judith et al. DOI: 10.1128/AAC.02174-20
PMID: 33559299 Journal: TRANSPLANT INTERNATIONAL Year: 2021 Reference: Transpl Int. 2021 May;34(5):865-871. doi: 10.1111/tri.13841. Epub 2021 Mar 13. Impact factor: Publication type: Paper in international publication Authors: Boergel, Martin; Bokhorst, Arlinke; Chandrasekar, Akila; Dominguez-Gil, Beatriz; Filipe Severino, Paulo; Oliveira, Josefina; Pont, Teresa; Ponzin, Diego; Sanchez Ibanez, Jacinto; Sandiumenge, Alberto et al. DOI: 10.1111/tri.13841
PMID: 33539280 Journal: Blood Transfusion Year: 2021 Reference: Blood Transfus. 2021 Mar;19(2):158-167. doi: 10.2450/2021.0259-20. Epub 2021 Jan 15. Impact factor: Publication type: Paper in international publication Authors: Argelagues, Enric; Coll, Ruth; Contreras, Enric; Delgadillo, Joaquin; Garcia-Lopez, Joan; Grifols, Joan Ramon; Guasch, Rosa; Herrero, Maria J; Lopez, Isabel; Madrigal, Alejandro et al. DOI: 10.2450/2021.0259-20
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
Divuit hores de programa solidari recull més de 8 milions d'euros per lluitar contra les malalties del cor. A Catalunya, una de cada quatre persones moren a causa d'una malaltia del cor o un ictus
Els premiats són un projecte de simulació per entrenar-se en maneig d'ECMO, un programa d’entrenament de treball en equip amb simulació i una base de dades que permet registre i consulta del procés de donació d'òrgans i teixits en temps real.
